What is the recommended dose of MgSO4 (magnesium sulfate) for a pregnant woman with Pregnancy-Induced Hypertension (PIH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MgSO4 Dosing for Pregnancy-Induced Hypertension

For women with pregnancy-induced hypertension (PIH), administer magnesium sulfate as a 4-6 gram IV loading dose over 20-30 minutes, followed by a maintenance infusion of 1-2 grams per hour for 24 hours postpartum. 1, 2

Standard IV Regimen (Preferred)

Loading Dose:

  • Administer 4-6 grams IV over 20-30 minutes 1, 2
  • The FDA-approved regimen for severe pre-eclampsia/eclampsia specifies 4-5 grams in 250 mL of 5% dextrose or 0.9% sodium chloride 3

Maintenance Dose:

  • Standard: 1-2 grams per hour by continuous IV infusion 1, 2
  • For patients with BMI ≥25 kg/m²: Start at 2 grams per hour rather than 1 gram per hour, as 70-80% of overweight patients reach therapeutic levels within 2-4 hours at this dose 2
  • Evidence from a 2019 randomized trial showed both 1 gram/hour and 2 grams/hour were equally effective in preventing eclampsia, though 2 grams/hour produced higher serum magnesium levels with more side effects 4

Duration:

  • Continue for 24 hours postpartum in most cases 1, 2
  • Maximum total duration should not exceed 5-7 days due to risk of fetal abnormalities 3

Alternative Pritchard Regimen (Resource-Limited Settings)

When continuous IV infusion is not feasible, use the combined IV/IM protocol validated in the MAGPIE trial: 2

Loading Dose:

  • 4 grams IV over 20-30 minutes PLUS 10 grams IM (5 grams in each buttock) 1, 2, 3

Maintenance Dose:

  • 5 grams IM every 4 hours in alternate buttocks for 24 hours 1, 2
  • This regimen is particularly valuable when IV access is limited or continuous monitoring is unavailable 2

Critical Safety Monitoring

Clinical Parameters (Monitor Continuously):

  • Patellar reflexes: Loss occurs at 3.5-5 mmol/L (first sign of toxicity) 5
  • Respiratory rate: Must be ≥12 breaths/minute; respiratory paralysis occurs at 5-6.5 mmol/L 1, 5
  • Urine output: Maintain ≥30 mL/hour (oliguria increases toxicity risk as magnesium is renally excreted) 1, 6
  • Oxygen saturation: Keep >90% 6

Laboratory Monitoring:

  • Serum magnesium levels are NOT routinely needed with standard dosing 6
  • Check levels only in high-risk situations: renal impairment, oliguria (<30 mL/hour), loss of reflexes, or respiratory rate <12 breaths/minute 6
  • Therapeutic range for seizure prevention: 1.8-3.0 mmol/L (4.8-7.2 mg/dL) 5

Absolute Contraindications and Critical Warnings

Never combine MgSO4 with calcium channel blockers (especially nifedipine) - this causes severe hypotension and myocardial depression 1, 2, 6

Fluid restriction:

  • Limit total fluid intake to 60-80 mL/hour to prevent pulmonary edema in preeclamptic patients with capillary leak 1, 2

Renal impairment:

  • Maximum dose is 20 grams/48 hours in severe renal insufficiency 3
  • Requires frequent serum magnesium monitoring 3

Toxicity management:

  • Antidote: 10 mL of 10% calcium gluconate IV 7
  • Immediately stop infusion if reflexes are lost or respiratory rate drops below 12 1

Common Pitfalls to Avoid

  • Do NOT use NSAIDs for postpartum pain in preeclamptic patients - they worsen hypertension and increase acute kidney injury risk 1, 2
  • Do NOT rely on proteinuria levels to guide MgSO4 administration; base decision on blood pressure and clinical signs 6
  • Do NOT continue beyond 5-7 days - prolonged use causes fetal abnormalities 3
  • In community settings where full protocols cannot be administered, give at least 10 grams IM total (5 grams each buttock) as loading dose before referral 2

Indications for MgSO4 in PIH

  • Blood pressure ≥160/110 mmHg with proteinuria 6
  • Moderate hypertension (≥150/100 mmHg) with proteinuria PLUS signs of imminent eclampsia (severe headache, visual scotomata, clonus, or epigastric pain) 6
  • Any woman with severe pre-eclampsia and at least one clinical sign of seriousness 6

Evidence Base

MgSO4 is superior to both phenytoin and diazepam for preventing eclamptic seizures - a 1995 randomized trial showed 10/1089 women on phenytoin developed eclampsia versus 0/1049 on MgSO4 (P=0.004) 8. This validates decades of clinical practice and is endorsed by ACOG, ISSHP, and European guidelines 1, 2, 6.

References

Guideline

Standard Starting Magnesium Infusion Rate for Postpartum Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

MgSO4 Loading Dose for Eclampsia Prophylaxis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Magnesium Sulfate in Severe Pre-eclampsia and Eclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.